These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9734559)

  • 21. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG; Thornton AE; Chen EY; Chan RC; Wong JO; Bergmann A; Falkai P; Pomarol-Clotet E; McKenna PJ; Stip E; Williams R; MacEwan GW; Wasan K; Procyshyn R;
    N Engl J Med; 2006 Feb; 354(5):472-82. PubMed ID: 16452559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine effects on hostility and aggression in schizophrenia.
    Volavka J; Zito JM; Vitrai J; Czobar P
    J Clin Psychopharmacol; 1993 Aug; 13(4):287-9. PubMed ID: 8376618
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM; Potkin SG; Daniel DG; Buckley PF
    J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
    Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A; Okamura T
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH; Kim SY; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coadministration of fluvoxamine increases serum concentrations of haloperidol.
    Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S
    J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC; Goff DC
    J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
    Dittert S; Soyka M; Winter C; Möller HJ
    Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
    [No Abstract]   [Full Text] [Related]  

  • 33. What is a recommended treatment for aggression in a patient with schizophrenia?
    Gobbi G; Debonnel G
    J Psychiatry Neurosci; 2003 Jul; 28(4):320. PubMed ID: 12921225
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluvoxamine treatment of compulsivity, impulsivity, and aggression.
    Poyurovsky M; Halperin E; Enoch D; Shneidman M; Weizman A
    Am J Psychiatry; 1995 Nov; 152(11):1688-9. PubMed ID: 7485638
    [No Abstract]   [Full Text] [Related]  

  • 35. The predictive value of benzodiazepine tolerance in persistently aggressive schizophrenia.
    Hatta K; Takahashi T; Nakamura H; Yamashiro H; Endo H; Kito K; Fujii S; Matsuzaki I; Masui K; Yonezawa Y
    Neuropsychobiology; 1999 May; 39(4):196-9. PubMed ID: 10343184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia and violence.
    Volavka J; Krakowski M
    Psychol Med; 1989 Aug; 19(3):559-62. PubMed ID: 2798630
    [No Abstract]   [Full Text] [Related]  

  • 37. [Patient escape].
    Petroni C
    MMW Fortschr Med; 2013 Oct; 155(18):10. PubMed ID: 24288902
    [No Abstract]   [Full Text] [Related]  

  • 38. The aggression theory of schizophrenia: revisited.
    Brown JS
    Neurosci Biobehav Rev; 1992; 16(1):39-42. PubMed ID: 1553105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggression in schizophrenia: assessment and prevalence.
    Soyka M
    Br J Psychiatry; 2002 Mar; 180():278-9. PubMed ID: 11872524
    [No Abstract]   [Full Text] [Related]  

  • 40. Family interaction patterns, drug treatment, and change in social aggression.
    Cohen M; Freedman N; Engelhardt DM; Margolis RA
    Arch Gen Psychiatry; 1968 Jul; 19(1):50-6. PubMed ID: 5661009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.